Back to Search
Start Over
Poster: MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia
- Source :
- Clinical Lymphoma Myeloma and Leukemia. 22:S160
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 21522650
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Clinical Lymphoma Myeloma and Leukemia
- Accession number :
- edsair.doi...........25f2f2a2c96e4c63f26575ecf77ff0db
- Full Text :
- https://doi.org/10.1016/s2152-2650(22)00983-1